Albumin administration in the acutely ill: what is new and where next?

Vincent, Jean-Louis; Russell, James A; Jacob, Matthias; Martin, Greg; Guidet, Bertrand; Wernerman, Jan; Ferrer, Ricard; Roca, Ricard Ferrer; McCluskey, Stuart A; Gattinoni, Luciano

Vincent, Jean-Louis; Russell, James A; Jacob, Matthias; Martin, Greg; Guidet, Bertrand; Wernerman, Jan; Ferrer, Ricard; Roca, Ricard Ferrer; McCluskey, Stuart A; Gattinoni, Luciano.

Crit Care ; 18(4): 231, 2014 Jul 16.

Article in En | MEDLINE | ID: mdl-25042164

Subject(s)

Albumins/therapeutic use; Critical Illness/therapy; Fluid Therapy/standards; Hypoalbuminemia/complications; Albumins/adverse effects; Albumins/history; Albumins/physiology; Brain Injuries; Clinical Trials as Topic; Cost-Benefit Analysis; Critical Care/methods; Critical Care/standards; Fluid Therapy/adverse effects; Fluid Therapy/methods; History, 20th Century; Humans; Hypoalbuminemia/etiology; Hypoalbuminemia/therapy; Resuscitation/methods; Sepsis/therapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Critical Illness / Hypoalbuminemia / Albumins / Fluid Therapy Type of study: Clinical_trials / Etiology_studies / Guideline Limits: Humans Language: En Journal: Crit Care Year: 2014 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google